Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10010882HBVENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS30067833HIVENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS20012857HPVENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS20062294HPVENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS20023366HPVENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS20022730HPVENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS20061784HPVENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS44016703HTLV-1ENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TVIS44049057HTLV-1ENSG00000105976.16protein_codingMETYesNo4233E6Y365
P08581
TCGA Plot Options
Drug Information
GeneMET
DrugBank IDDB08865
Drug NameCrizotinib
Target IDBE0000915
UniProt IDP08581
Regulation Typeinhibitor
PubMed IDs22594847; 10592235
CitationsForde PM, Rudin CM: Crizotinib in the treatment of non-small-cell lung cancer. Expert Opin Pharmacother. 2012 Jun;13(8):1195-201. doi: 10.1517/14656566.2012.688029.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved; Investigational
Direct ClassificationPyrazolylpyridines
SMILESC[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
Pathways
PharmGKBPA165946122
ChEMBLCHEMBL601719